SCHEMBL7072263

SCHEMBL7072263

CCOC(=O)C(Cc1ccccc1OCc1cc(-c2ccccc2)nc2ccccc12)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.47
KDM4E B2RXH2 6/20 0.46
ALDH1A1 P00352 5/20 0.46
HPGD P15428 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
MAPT P10636 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
ADAM17 P78536 3/20 0.45
LMNA P02545 3/20 0.43
MAPK1 P28482 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
AHR P35869 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41
PPARG P37231 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7068765 0.92 PPARG (0.47) TP53KDM4EALDH1A1HPGDL3MBTL1
SCHEMBL7072259 0.85 ADAM17 (0.56) TP53KDM4EALDH1A1HPGDL3MBTL1
SCHEMBL7069921 0.82 ALOX15 (0.41) NPC1CYP1A2CYP2C9PDE10A
SCHEMBL27541825 0.79 PPARA (0.50) L3MBTL1MAPTTDP1LMNAMAPK1
SCHEMBL7069567 0.78 PPARG (0.42) TP53KDM4EMAPTMAPK1RAB9A
SCHEMBL7066781 0.78 CYP1A2 (0.42) KDM4EALDH1A1MAPTLMNARAB9A
SCHEMBL7068758 0.77 PPARA (0.60) KDM4EALDH1A1HPGDADAM17LMNA
SCHEMBL7069545 0.76 KDM4E (0.45) TP53KDM4EALDH1A1HPGDL3MBTL1
SCHEMBL7072000 0.75 PPARG (0.44) PPARGPPARDPPARA
SCHEMBL7071834 0.75 PPARA (0.43) PPARGPPARDPPARACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed
EP-1266888-A1 QUINOLINE DERIVATIVES AND MEDICINAL USE THEREOF Mitsui Chemicals, Inc. (JP) 2002-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA TP53 571/4885KDM4E 3239/4885ALDH1A1 822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.